Market Snapshot: U.S. stock futures steady on eve of half-point Fed hike

This post was originally published on this site

U.S. stock futures were steady Tuesday, on the eve of what’s expected to be the most aggressive Federal Reserve tightening in two decades.

What’s happening
  • Futures on the Dow Jones Industrial Average
    YM00,
    +0.03%

    fell 5 points, or 0% to 32975.

  • Futures on the S&P 500
    ES00,
    +0.06%

    gained 0.25 points, or 0%, to 4151.

  • Futures on the Nasdaq 100
    NQ00,
    +0.07%

    decreased 8.25 points, or 0.1% to 13065.

On Monday, the Dow Jones Industrial Average
DJIA,
+0.26%

rose 84 points, or 0.26%, to 33062, the S&P 500
SPX,
+0.57%

increased 23 points, or 0.57%, to 4155, and the Nasdaq Composite
COMP,
+1.63%

gained 201 points, or 1.63%, to 12536.

What’s driving markets

The Federal Open Market Committee on Tuesday kicks off its two-day meeting, that is expected to end in its first half-point rate hike since 2020, as well as the launch of its quantitative tightening policy of selling bonds.

Both stocks and bonds suffered a miserable April, with the S&P 500 sliding nearly 9% and the JPMorgan U.S. Aggregate Bond ETF
JAGG,
-0.63%

dropping 4%.

“Perhaps one of the most interesting shifts seen over the first four months of the year is a move from a market being backstopped by a ‘Fed put’, where ‘buying the dip’ was an infallible strategy, to one operating with a ‘Fed call’, with selling into strength ruling the roost,” said Michael Brown, head of market intelligence at Caxton.

“Such a ‘Fed call’ comes about as a result of policymakers actively wanting to see a tightening in financial conditions, as noted by Chair Powell himself at the last press conference.”

A reminder that not just the Fed is tightening came from the Reserve Bank of Australia, which started its rate-hike cycle with a 25-basis point increase. The Bank of England meets Thursday and also is expected to lift rates.

Corporate earnings season rolls on with results from companies including Pfizer
PFE,
-1.49%
,
Biogen
BIIB,
-0.06%
,
and after the close, Advanced Micro Devices
AMD,
+5.05%

and Starbucks
SBUX,
+0.98%
.

Market participants might also be discussing the political, and therefore economic, consequences of the reported draft ruling that would overturn the landmark Roe vs. Wade decision that legalized abortion.

Add Comment